Cover Image

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells

Show other versions (1)
Saved in:
Bibliographic Details
Main Authors: Merz, Patrick (Author) , Röckel, Nina (Author) , Ballikaya, Seda (Author) , Auffarth, Gerd U. (Author) , Schmack, Ingo (Author)
Format: Article (Journal)
Language:English
Published: London BioMed Central 01 Feb. 2019
Heidelberg Universitätsbibliothek Heidelberg 01 Feb. 2019
DOI:https://doi.org/10.1186/s12886-018-0978-9
Online Access:Resolving-System, kostenfrei, Volltext: http://dx.doi.org/https://doi.org/10.1186/s12886-018-0978-9
Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-257445
Get full text
Author Notes:Patrick R. Merz, Nina Röckel, Seda Ballikaya, Gerd U. Auffarth and Ingo Schmack
Description
Item Description:Aus: BMC Ophthalmology, 18 (2018), Nr. 316. pp. 1-8. ISSN 1471-2415
Physical Description:Online Resource
DOI:https://doi.org/10.1186/s12886-018-0978-9

Similar Items